SuperworthRecursion Pharmaceuticals shares outstanding RXRX
Diluted shares outstanding, averaged over each quarter, from 2020.
- Latest quarter, to Jun 30, 2026
- 532.5M
- On a year earlier
- +27.6%
- more shares
Recursion Pharmaceuticals had 532.5M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 27.6% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 521M | +55% |
| FY2024 | 336M | +51% |
| FY2023 | 222M | +20% |
| FY2022 | 185.7M | +10% |
| FY2021 | 169.4M | +669% |
| FY2020 | 22M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 532.5M | +28% | |
| Q1 FY26 | 529.3M | +31% | |
| Q4 FY25 | 521M | +55% | |
| Q3 FY25 | 447M | +58% | |
| Q2 FY25 | 417.4M | +72% | |
| Q1 FY25 | 402.8M | +71% | |
| Q4 FY24 | 336M | +51% | |
| Q3 FY24 | 282.6M | +32% | |
| Q2 FY24 | 242.2M | +20% | |
| Q1 FY24 | 236M | +23% | |
| Q4 FY23 | 222M | +20% | |
| Q3 FY23 | 214.3M | +24% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Recursion Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.